This paper presents an updated and revised summary of the ‘core data set' that has been proposed to be recorded and reported in all clinical trials on infant nutrition by the recently formed Consensus Group on Outcome Measures Made in Paediatric Enteral Nutrition Clinical Trials (COMMENT). This core data set was developed based on a previous proposal by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition in 2003. It comprises confidential data to identify subjects and facilitate contact for further follow-up, data to characterize the cohort studied and data on withdrawals from the study, and some additional core data for all nutrition studies on preterm infants. We recommend that all studies on nutrition in infancy should collect and report this core data set to facilitate interpretation and comparison of results from clinical studies, and of systematic data evaluation and meta-analyses. Editors of journals publishing such reports are encouraged to require the reporting of the minimum data set described here either in the main body of the publication or as supplementary online material. © 2014 S. Karger AG, Basel

1.
Koletzko B, Szajewska H, Ashwell M, Shamir R, Aggett P, Baerlocher K, et al: Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENT. Ann Nutr Metab 2012;60:222-232.
2.
Aggett P, Agostoni C, Axelsson I, Goulet O, Hernell O, Koletzko B, et al: Core data for nutrition trials in infants: a discussion document - a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:338-342.
3.
Welch RW, Antoine JM, Berta JL, Bub A, de Vries J, Guarner F, et al: Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr 2011;106(suppl 2):S3-S15.
4.
Gallagher AM, Meijer GW, Richardson DP, Rondeau V, Skarp M, Stasse-Wolthuis M, et al: A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance. Br J Nutr 2011;106(suppl 2):S16-S28.
5.
Koletzko B, Ashwell M, Beck B, Bronner A, Mathioudakis B: Characterisation of infant food modifications in the European Union. Ann Nutr Metab 2002;46:231-242.
6.
Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251.
7.
Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al: Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781-788.
8.
Vermont-Oxford-Network. Manual of Operations for Infants Born in 2008. Release 12.1, updated Feb 2008. www.vtoxford.org/tools/2008ManualofOperationswithindex12_1.pdf.
9.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al: Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
10.
Kliegman RM, Walsh MC: Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17:213-288.
11.
Volpe JJ, de Vries LS: Neurology of the newborn. Intracranial hemorrhages and vascular lesions; in Martin RJ, Fanaroff AA, Walsh MC (eds): Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. Philadelphia, Mosby, 2006, pp 924-933.
12.
Khwaja O, Volpe JJ: Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93:F153-F161.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.